l
The patient is a 70 year old male who was diagnosed with AML-M1 and underwent two standard induction therapies. He was then placed on Mylotarg as therapy for residual disease. His CBC at this time showed a hemoglobin of 10g/dL, WBC of 5k/uL with a normal differential and a platelet count of 446k/uL. A peripheral smear shows moderate anisocytosis and poikilocytosis. Microspherocytes, polychromatophilic and fragmented RBCs are present. Tear-drop RBCs can also be seen.
Metastatic Prostatic Carcinoma - 1.
Author:
John Lazarchick
Category: Laboratory Hematology > Non-hematopoietic malignancies involving the blood or bone marrow
Published Date: 09/28/2011
Category: Laboratory Hematology > Non-hematopoietic malignancies involving the blood or bone marrow
Published Date: 09/28/2011
The patient is a 70 year old male who was diagnosed with AML-M1 and underwent two standard induction therapies. He was then placed on Mylotarg as therapy for residual disease. His CBC at this time showed a hemoglobin of 10g/dL, WBC of 5k/uL with a normal differential and a platelet count of 446k/uL. A peripheral smear shows moderate anisocytosis and poikilocytosis. Microspherocytes, polychromatophilic and fragmented RBCs are present. Tear-drop RBCs can also be seen.
